ConvaTec Group PLC (LON:CTEC) Rating Reiterated by Deutsche Bank AG
ConvaTec Group PLC (LON:CTEC)‘s stock had its “buy” rating reissued by research analysts at Deutsche Bank AG in a note issued to investors on Sunday, StockTargetPrices.com reports. They currently have a GBX 330 ($4.30) price objective on the stock. Deutsche Bank AG’s price objective indicates a potential upside of 13.68% from the company’s previous close.
Several other brokerages also recently weighed in on CTEC. Peel Hunt restated a “buy” rating and set a GBX 380 ($4.95) target price on shares of ConvaTec Group PLC in a research note on Thursday, August 3rd. Numis Securities Ltd reaffirmed a “hold” rating and set a GBX 276 ($3.59) price target on shares of ConvaTec Group PLC in a research report on Thursday, May 4th. Goldman Sachs Group, Inc. (The) reaffirmed a “buy” rating and set a GBX 340 ($4.43) price target on shares of ConvaTec Group PLC in a research report on Thursday, August 3rd. J P Morgan Chase & Co increased their price target on shares of ConvaTec Group PLC from GBX 305 ($3.97) to GBX 318 ($4.14) and gave the stock an “overweight” rating in a research report on Friday, May 5th. Finally, Morgan Stanley reaffirmed an “equal weight” rating on shares of ConvaTec Group PLC in a research report on Thursday, May 4th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average price target of GBX 312.33 ($4.07).
Shares of ConvaTec Group PLC (LON CTEC) opened at 290.30 on Friday. ConvaTec Group PLC has a one year low of GBX 213.00 and a one year high of GBX 349.10. The firm’s 50-day moving average price is GBX 311.30 and its 200-day moving average price is GBX 285.90. The stock’s market capitalization is GBX 5.59 billion.
ILLEGAL ACTIVITY WARNING: This news story was reported by Daily Political and is the property of of Daily Political. If you are reading this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright law. The legal version of this news story can be read at https://www.dailypolitical.com/2017/08/07/convatec-group-plc-lonctec-rating-reiterated-by-deutsche-bank-ag-2.html.
About ConvaTec Group PLC
ConvaTec Group Plc is a medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions.
Receive News & Ratings for ConvaTec Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.